Skip to main content

Advertisement

Log in

High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objects

To explore the roles of growth factor receptor-bound protein 14 (GRB14) in colorectal cancer (CRC) and its correlation with clinicopathological characteristics and prognosis of CRC patients.

Results

GRB14 was localized in the cytoplasm of CRC and benign glandular epithelium cells, showing higher levels in CRC tissues compared with normal colon samples (P < 0.001). High GRB14 was associated with a high pathological grade (P = 0.045), advanced clinical stage (P = 0.018), enhanced tumor invasion (P < 0.001) and lymph node metastasis (P = 0.028). The cancer genome atlas (TCGA) mRNA sequence data showed that GRB14 was upregulated in CRC at an advanced clinical stage (P = 0.011) with enhanced tumor invasion (P < 0.001) and lymph node metastasis (P = 0.014). Kaplan–Meier survival curves revealed that CRC patients with high GRB14 levels had a shorter survival compared with those showing low GRB14 expression (P = 0.007). High GRB14 expression was an independent prognostic factor for CRC patients (HR 2.847, 95 %CI 1.058–7.659; P = 0.038).

Conclusions

GRB14 may be an important cancer promoter that enhances CRC progression. Upregulated GRB14 levels may predict a poor clinical outcome in CRC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Balogh K, Asa SL, Zheng L, Cassol C, Cheng S, Ezzat S (2012) The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression. Oncogene 36:4012–4021

    Article  Google Scholar 

  • Cai C, Chen JY, Han ZD, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Zou J, Liang YX, Dai QS, Jiang FN, Zhong WD (2015) Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. Int J Clin Exp Med 3:4186–4194

    Google Scholar 

  • Cariou B, Bereziat V, Moncoq K, Kasus-Jacobi A, Perdereau D, Le Marcis V, Burnol AF (2004) Regulation and functional roles of Grb14. Front Biosci 9:1626–1636

    Article  CAS  PubMed  Google Scholar 

  • Daly RJ, Sanderson GM, Janes PW, Sutherland RL (1996) Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J Biol Chem 21:12502–12510

    Article  Google Scholar 

  • Depetris RS, Hu J, Gimpelevich I, Holt LJ, Daly RJ, Hubbard SR (2005) Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14. Mol Cell 20:325–333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 5:518–527

    Article  Google Scholar 

  • Han DC, Shen TL, Guan JL (2001) The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 44:6315–6321

    Article  Google Scholar 

  • Huang O, Jiang M, Zhang X, Xie Z, Chen X, Wu J, Liu H, Shen K (2013) Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapy. Jpn J Clin Oncol 11:1064–1072

    Article  Google Scholar 

  • Ikeda T, Jinno H, Shirane M (2007) Chemosensitivity-related genes of breast cancer detected by DNA microarray. Anticancer Res 27:2649–2655

    CAS  PubMed  Google Scholar 

  • Li X, Liang L, Huang L, Ma X, Li D, Cai S (2015) High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Mol Cancer 14:1–13

    Article  Google Scholar 

  • Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC, Palacios J, Lakhani SR, Ashworth A (2006) FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 22:6652–6662

    Article  Google Scholar 

  • Rosa PR, Bohrer RC, De Cesaro MP, Gutierrez K, Ferreira R, Pereira GR, Oliveira JF, Goncalves PB (2014) Growth factor receptor-bound protein 14: a potential new gene associated with oocyte competence. Zygote 22:103–109

    Article  CAS  PubMed  Google Scholar 

  • Torre LA, Bray F, Siegel RL, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA 65:87–102

    Article  PubMed  Google Scholar 

  • Wang GH, Yao L, Xu HW, Tang WT, Fu JH, Hu XF, Cui L, Xu XM (2013) Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett 2:544–548

    Google Scholar 

  • Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J, Peng H, Liu R, Pan C, Huang W (2014) OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer 13:1–14

    Article  Google Scholar 

Download references

Acknowledgments

The present study was supported by the Grant from National Natural Science Foundation of China (81272556).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie Cao.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, P., Wei, J., Li, W. et al. High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients. Biotechnol Lett 38, 1043–1047 (2016). https://doi.org/10.1007/s10529-016-2077-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-016-2077-4

Keywords

Navigation